Tonix Pharma (TNXP) Reports In-Line Q3 EPS

Tonix Pharma (NASDAQ: TNXP) reported Q3 EPS of ($3.59), in-line with the analyst estimate of ($3.59). Revenue for the quarter came in at $3.29 million versus the consensus estimate of $3.1 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• Bessent: We Make A Market Buying Older Bonds
• Intel (INTC) call put ratio 2.5 calls to 1 put with a focus on October 2 weekly calls as share price up 7.8%
• EU And Canada Plan Far-reaching Deal To Strengthen Partnership - Bloomberg